Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 26:12:932309.
doi: 10.3389/fcimb.2022.932309. eCollection 2022.

Gut microbiota: Linking nutrition and perinatal depression

Affiliations
Review

Gut microbiota: Linking nutrition and perinatal depression

Jia Song et al. Front Cell Infect Microbiol. .

Erratum in

Abstract

Perinatal depression is a mood disorder that is reported in women during pregnancy (prenatal) and after childbirth (postnatal). The onset of perinatal depression is associated with changes in reproductive hormones, stress hormones and neurosteroids. These chemical compounds can be modulated by the gut microbiota, which may affect maternal mental health during the perinatal period via the gut-brain-axis. Recent studies suggest that nutritional and dietary interventions (vitamin D, ω-3 fatty acids, iron, and fiber) effectively prevent or mitigate maternal depression and anxiety, but their efficacy is confounded by various factors, including the gut microbiota. Probiotics are efficacious in maintaining microbiota homeostasis, and thus, have the potential to modulate the development of perinatal mood disorders, despite no evidence in human. Therefore, clinical trials are warranted to investigate the role of probiotic supplementation in perinatal depression and behavioral changes. This article reviews the interplay between nutrition, gut microbiota and mood and cognition, and the evidence suggesting that probiotics affect the onset and development of perinatal depression.

Keywords: fiber; microbiota; nutrition; perinatal depression; probiotics.

PubMed Disclaimer

Conflict of interest statement

Author JC was employed by company Ingredion Incorporated. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Diet and nutrition may regulate perinatal depression via the microbiota-gut-brain axis by influencing systemic biomarkers including estrogen, neurotransmitters, inflammatory cytokines and microbial metabolites. The role of probiotics on perinatal depression is controversial.
Figure 2
Figure 2
GUS-coding microbiota produces GUS to cleave and activate conjugated estrogen, which is released to the circulating system and binds to ERα, resulting in alleviated depression in women with low estrogen. GUS, β-glucuronidase; ER, estrogen receptor.
Figure 3
Figure 3
Microbiota dysbiosis increases pro-inflammatory cytokines, which promote the differentiation of naïve autoreactive CD4+ T-cells in Th17 cells and subsequently cause neurodegeneration. Elevated pro-inflammatory cytokines can also impair the tight junctions, leading to the intestinal transport of microorganisms and bacterial toxins, causing neuroinflammation. Microbiota dysbiosis decreases SCFAs, which exhibit neuroprotective functions by enhancing the intestinal tight junction and up-regulating the PPARγ and Nrf2 signaling pathways.
Figure 4
Figure 4
Action mechanisms of probiotics on depression via regulating systemic biomarkers. CRF, Corticotropin releasing factor; ACTH, adrenocorticotropic hormone; MAPK, MAP kinase; GABA, γ-Aminobutyric acid. Red squares indicate an increased level in depressive patients; green squares indicate a decreased level in depressive patients.

Similar articles

Cited by

References

    1. Abildgaard A., Elfving B., Hokland M., Wegener G., Lund S. (2017). Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology 79, 40–48. doi: 10.1016/j.psyneuen.2017.02.014 - DOI - PubMed
    1. Addolorato G., Capristo E., Stefanini G., Gasbarrini G. (1997). Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J. Gastroenterol. 32 (10), 1013–1021. doi: 10.3109/00365529709011218 - DOI - PubMed
    1. Ahokas A., Kaukoranta J., Wahlbeck K., Aito M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J. Clin. Psychiatry 62 (5), 332–336. doi: 10.4088/JCP.v62n0504 - DOI - PubMed
    1. Ait-Belgnaoui A., Durand H., Cartier C., Chaumaz G., Eutamene H., Ferrier L., et al. . (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37 (11), 1885–1895. doi: 10.1016/j.psyneuen.2012.03.024 - DOI - PubMed
    1. Alcocer-Gómez E., de Miguel M., Casas-Barquero N., Núñez-Vasco J., Sánchez-Alcazar J. A., Fernández-Rodríguez A., et al. . (2014). NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain behavior Immun. 36, 111–117. doi: 10.1016/j.bbi.2013.10.017 - DOI - PubMed